TY - JOUR
T1 - Estimating Hospitalization Expenditures Associated with Chronic Diseases and Multimorbidity for Older Adults — Guangzhou City, Guangdong Province, China, 2017–2019
AU - Zhao, Fei
AU - Li, Yang
AU - Lou, Xuyan
AU - Li, Molin
AU - Ma, Chao
AU - Xu, Wei
AU - Fan, Yangdong
AU - Jiao, Yang
AU - Wu, Yihan
AU - Chen, Zhuo
N1 - Publisher Copyright:
© 2025 by Chinese Center for Disease Control and Prevention.
PY - 2025
Y1 - 2025
N2 - Introduction: Chronic diseases and multimorbidity are increasingly prevalent among older adults in China, contributing substantially to hospitalization burden. However, real-world evidence on their direct medical expenditures remains limited. Methods: This study employed a retrospective analysis by using hospital discharge data from Guangzhou during 2017–2019, and adopted generalized linear models (GLMs) to estimate hospitalization expenditures across chronic disease and multimorbidity patterns. Results: Older patients with multimorbidity incurred nearly double the median annual hospitalization expenditures (3,708 USD vs. 1,844 USD) and 45% higher costs per additional condition compared to single diseases. Hospitalization cost varied by specific diseases and multimorbidity patterns. Schizophrenia (7,421.3 USD) has the highest annual total hospitalization expenditure (THE) among single chronic diseases while the combination of cancer + CVD + heart disease (10,698.8 USD for THE, 4,024.6 USD for out-of-pocket expenditure) ranked the top expenditures among multimorbidity patterns. Approximately 57.1% of disease combinations exhibited super-additive spending. Conclusion: This study provides robust evidence of the substantial economic burden of chronic diseases and multimorbidity. The findings underscore the need for an integrated care model, evidence-based strategies to optimize healthcare resource allocation and health outcomes in aging populations.
AB - Introduction: Chronic diseases and multimorbidity are increasingly prevalent among older adults in China, contributing substantially to hospitalization burden. However, real-world evidence on their direct medical expenditures remains limited. Methods: This study employed a retrospective analysis by using hospital discharge data from Guangzhou during 2017–2019, and adopted generalized linear models (GLMs) to estimate hospitalization expenditures across chronic disease and multimorbidity patterns. Results: Older patients with multimorbidity incurred nearly double the median annual hospitalization expenditures (3,708 USD vs. 1,844 USD) and 45% higher costs per additional condition compared to single diseases. Hospitalization cost varied by specific diseases and multimorbidity patterns. Schizophrenia (7,421.3 USD) has the highest annual total hospitalization expenditure (THE) among single chronic diseases while the combination of cancer + CVD + heart disease (10,698.8 USD for THE, 4,024.6 USD for out-of-pocket expenditure) ranked the top expenditures among multimorbidity patterns. Approximately 57.1% of disease combinations exhibited super-additive spending. Conclusion: This study provides robust evidence of the substantial economic burden of chronic diseases and multimorbidity. The findings underscore the need for an integrated care model, evidence-based strategies to optimize healthcare resource allocation and health outcomes in aging populations.
UR - https://www.scopus.com/pages/publications/105013393028
U2 - 10.46234/ccdcw2025.175
DO - 10.46234/ccdcw2025.175
M3 - Article
AN - SCOPUS:105013393028
SN - 2096-7071
VL - 7
SP - 1031
EP - 1037
JO - China CDC Weekly
JF - China CDC Weekly
IS - 31
ER -